
FDA grants 510(k) clearance to cobas liat STI multiplex assay panels
The new panels, leveraging rapid polymerase chain reaction technology, allow point of care sexually transmitted infection diagnosis in 20 minutes, enhancing targeted treatment and reducing follow-up losses.


























